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1571 ABSTRACT 
The process of the present invention relates to a three 
dimensional co-culture process. Wherein two distinct 
types of mammalian cells are co-cultured in a rotating 
bioreactor which is completely filled with culture 
media and cell attachment substrates. As the size of the 
tissue assemblies formed on the attachment substrates 
changes the rotation of the bioreactor is adjusted ac- 
cordingly. 
10 Claims, No Drawings 
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THREE-DIMENSIONAL CO-CULTURE PROCESS 
ORIGIN O F  T H E  INVENTION 
The invention described herein was made in the per- 
formance of work under NASA contract and is subject 
to provisions of Section 305 of the National Aeronautics 
and Space Act of 1958, public Law 85-568 (72 Stat. 435; 
42 U.S.C. 2457). 
RELATED APPLICATIONS 
This application is a continuation-in-part application 
of U.S. patent applications Ser. No. 7/213,558 filed Jun. 
30, 1988 now U.S. Pat. No. 5,026,660 and Ser. No. 
7/213,559 filed Jun. 30, 1988, now U.S. Pat. No. 
4,988,623 and a US .  patent application entitled “Three- 
Dimensional Cell to Tissue Assembly Process” Ser. No. 
7/317,176 filed Mar. 2, 1989, all of which are specifi- 
cally incorporated as if fully set forth herein. 
FIELD O F  T H E  INVENTION 
The process of the present invention relates to a 3- 
dimensional coculture process. By the process of the 
present invention a variety of cells may be co-cultured 
to produce tissue which has 3-dimensionality and has 
some of the characteristics of in vivo tissue. The process 
provides enhanced 3-dimensional tissue which creates a 
multicellular organoid differentiation model. 
BACKGROUND O F  T H E  INVENTION 
Cell culture processes have been developed for the 
growth of single cell bacteria, yeast and molds which 
are resistant to environmental stresses or are encased 
with a tough cell wall. Mammalian cell culture, how- 
ever, is much more complex because such cells are more 
delicate and have more complex nutrient and other 
environmental requirements in order to maintain viabil- 
ity and cell growth. Large scale culture of bacterial 
type cells is highly developed and such culture pro- 
cesses are less demanding and are not as difficult to 
cultivate as mammalian cells. These techniques are 
highly empirical and a firm theoretical basis is not de- 
veloped. Bacterial cells can be grown in large volumes 
of liquid medium and can be vigorously agitated with- 
out any significant damage. Mammalian cells, on the 
other hand, cannot withstand excessive turbulent action 
without damage to the cells and must be provided with 
a complex nutrient medium to support growth. 
In addition, mammalian cells have other special re- 
quirements, in particular most animal cells must attach 
themselves to some substrate surface to remain viable 
and to duplicate. On a small scale, mammalian cells 
have been grown in containers with small microwells to 
provide surface anchors for the cells. However, cell 
culture processes for mammalian cells in such mi- 
crowell containers generally do not provide sufficient 
surface area to grow mammalian cells on a sufficiently 
large scale basis for many commercial or research appli- 
cations. To provide greater surface areas, microcarrier 
beads have been developed for providing increased 
surface areas for the cultured cells to attach. Microcar- 
rier beads with attached cultured cells require agitation 
in a conventional bio-reactor vessel to provide suspen- 
sion of the cells, distribution of fresh nutrients, and 
removal of metabolic waste products. T o  obtain agita- 
tion, such bio-reactor vessels have used internal propel- 
lers or movable mechanical agitation devices which are 
motor driven so that the moving parts within a vessel 
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cause agitation in the fluid medium for the suspension of 
the microcarrier beads and attached cells. Agitation of 
mammalian cells, however, subjects them to high de- 
grees of shear stress which can damage the cells and 
limits ordered assembly of these cells according to cell 
derived energy. These shear stresses arise when the 
fluid media has significant relative motion with respect 
to vessel walls, impellers, or other vessel components. 
Cells may also be damaged in bio-reactor vessels with 
internal moving parts if the cells or beads with cells 
attached collide with one another or vessel compo- 
nents. 
In addition to the drawbacks of cell damage, bio- 
reactors and other methods of culturing mammalian 
cells are also very limited in their ability to provide 
conditions which allow cells to assemble into tissues 
which simulate the spatial three-dimensional form of 
actual tissues in the intact organism. Conventional tissue 
culture processes limit, for similar reasons, the capacity 
for cultured tissues to express a highly functionally 
specialized or differentiated state considered crucial for 
mammalian cell differentiation and secretion of special- 
ized biologically active molecules of research and phar- 
maceutical interest. Unlike microorganisms, the cells of 
higher organisms such as mammals form themselves 
into high order multicellular tissues. Although the exact 
mechanisms of this self-assembly are not known, in the 
cases that have been studied thus far, development of 
cells into tissues has been found to be dependent on 
orientation of the cells with respect to each other (the 
same or different type of cell) or other anchorage sub- 
strate and/or the presence or absence of certain sub- 
stances (factors) such as hormones, autocrines, or para- 
crines. In summary, no conventional culture process is 
capable of simultaneously, achieving sufficiently low 
shear stress, sufficient 3-dimensional spatial freedom, 
and sufficiently long periods for critical cell interactions 
(with each other or substrates) to allow excellent mod- 
eling of in vivo tissue structure. 
Paper entitled “The Clinostat-A Tool For Analyz- 
ing The Influence of Acceleration On Solid-Liquid 
Systems” by W. Brieoleb, was published by the pro- 
ceedings of a workshop on Space biology, Cologne 
Germany, on Mar. 11, 1983, (ESASP-206, May 1983). 
In this paper, clinostat principles are described and 
analyzed relative to gravity effects. Some clinostat ex- 
periments are described including experiments where 
monocellular suspended organisms (protozoans) are , 
placed within cylinders which are rotated about a hori- 
zontal axis. 
A paper entitled, “The Large-Scale Cultivation of 
Mammalian Cells”, by Joseph Feder and William R. 
Tolbert, was published in the Scientific American, Jan- 
uary 1983, Vol. 248, No. 1. pps. 36-43. In this paper, 
agitation of the cells is described as required to  keep the 
cells suspended in the medium and describes a turbine 
agitator, a marine propeller agitator, and a vibro mixer 
for mixing. The paper also describes a perfusion reactor 
60 in which -an agitation is provided by four slowly rotat- 
ing flexible sheets of monofilament nylon which are 
rotated about a vertical axis while the medium in the 
main vessel is continuously pumped to the satellite filter 
vessel. The filter retains the cells which are pumped 
65 along with the remainder medium back into the vessel 
for further proliferation. 
A paper entitled, “Gravisensitivity of the Acellular, 
Slime, Mold, Physarum, Polycephalum Demonstrated 
5,153,132 
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on the Fast Rotating Clinostat”, by Ingrid Block and tissues, and substrates in a similar spatial region for the 
Wolfgang Brigley, published in the European Journal, duration of the cell culture (collocation). Transient 
of Cell Biology 41, pps. 44-50, 1986 describes rotation disruptions of this stabilized environment are permitted 
of a culture vessel about a horizontal axis for the simula- and well tolerated for logistical purposes during initial 
tion of weightlessness. 5 system priming, sample acquisition, system mainte- 
Paper entitled “Cell and Environment Interactions in 
Tumor Microregions: The Multicell Spheroid Model”, 
by Robert M. Sutherland, Science 240: 177-184, (1988) 
discloses the use of multicell spheroids, without attach- 
ment substrates, of tumor cells to study cell and envi- 
ronment interactions in tumors. Conventional culture 
processes are utilized to produce limited size and viabil- 
ity tumor cell aggregates. 
Cell cultures from various bio-reactors, including a 
slow turning lateral vessel (STLV) designed for batch 
culture of cells were presented at a poster session at the 
First Canadian Workshop on R & D Opportunities on 
Board the Space Station, National Research Council 
Canada, May 6-8, 1987, Ottawa, Canada, and published 
nance, and culture termination. The cultured 3-dimen- 
sional tissues (and substrates) increase in size as the 
culture progresses necessitating appropriate adjustment 
of rotational rates with respect to vessel dimensions, 
0 external gravitational strength, and absolute sedimenta- 
tion rate through the media in order to optimize these 
particle paths. Increased external gravity field strength 
and increased tissue (and substrate) sedimentation rate 
induce restrictions on the choice of parameters which 
5 ultimately limits the useful operating range of the pro- 
cess. These same factors place a lower limit on the shear 
stress obtainable even within the process operating 
range due to gravitationally induced drift of the parti- 
cles through the culture media. Calculations and mea- 
in the Proceedings “Spacebound ’87”, as a paper enti- 2 0  surementsplace this minimum shear stress very nearly 
tled “Growth and Maintenance of Anchorage Depen- to that resulting from the particles, terminal velocity 
dent Cells in Zero Headspace Bioreactor Systems De- (through the culture media) for the external gravity 
signed For Microgravity”, by Lewis et al. field strength Centrifugal and coriolus induced motion 
Paper entitled “Culturing Hepatocyte and other Dif- along with secondary effects due to particle and fluid 
ferentiated Cells”, by Lola M. Reid and Douglas M. 25 interactions act to further degrade the shear stress level 
Jefferson, Hepatology Vol. 4 No. 3 pp 548-560 (1984) as the growing tissue increases in size. 3-dimensionality 
discloses limited techniques for the coculturing of hepa- for spatial orientation of cells, substrates, and tissues is 
tocytes and other differentiated cells. The techniques optimized by selecting vessel dimensions and rotational 
disclosed in the paper make use of floating collagen rates which minimize collisions of the cultured particles 
gels, which are severely restricted in their 3-dimen- 30 with vessel walls or internal components. Again, in- 
sional aspect and cocultured with fibroblasts moder- creased gravity and particle sedimentation rate (which 
ately to cocultivate differentiated layers of tissue. These is proportional to size in all cases in our experience) 
techniques do not permit macroscopic inspection of the cause restrictions to the process operating range in 
tissue being cultured as a result of the limited size of the terms of maintaining 3-dimensional freedom. The par- 
resulting tissue. 35 ticular paths which result from rotation of cells, tissues, 
Paper entitled “Tissue Culture Model of Adenoma and substrates about an axis nearly perpendicular to 
Invasion” by Eileen A. Friedman Seminars in Surgical gravity result in these particles, which may differ 
Oncology 3:171-173 (1987) discloses a model for use of greatly in sedimentation rates, to remain spatially local- 
2-dimensional cocultivation to study the destructive. ized in similar regions for extended periods of time. This 
capability of colon carcinoma cells when exposed to 40 allows these particles sufficient time to interact as neces- 
normal adenoma cells. This destructive capability is sary to form multi-cellular structures and to associate 
further enhanced by tumor promoters which stimulate with each other. The ability to retain this spatial approx- 
the two cell activitv. imation of particles, which may differ in sedimentation 
properties, is degraded by increasing gravity and by 
45 increasing particle sedimentation rate. In all three cases 
minimizing fluid shear stress, maintaining 3-dimensional 
freedom for spatial orientation, and maximizing spatial 
approximation of particles with differing sedimentation 
properties we observe a degradation of performance 
50 with increasing external gravitational field strength and 
with increasing particle sedimentation rate. This then 
forms the basis for further enhancement of this process 
SUMMARY OF T H E  INVENTION 
The process of the present invention is directed to 
co-culturing cells to produce multicellular organoid 
tissue. The process forms and maintains 3-dimensional 
tissue of such a size as to create a multicellular organoid 
differentiation model. Combinations of cells of a wide 
variety may be cultured and maintained so that differen- 
tiation and de-differentiation may be studied. 
in a reduced gravity environment. These three criteria 
then form the basis for optimization of the culture envi- 
55 ronment. This process provides the necessary means for 
DETAILED DESCRIPTION OF THE 
INVENTION 
The co-culturing process of the present invention 
optimizes a group of culture environmental conditions, 
even as the culturing progresses, in a manner which 
greatly enhances the capability to form and maintain 
3-dimensional living tissue from either dissociated 
source cells or intact tissue resections. The 3-dimen- 
sional living tissues are formed and maintained from 
cells, which is used herein to include cells in any form, 
for example, individual cells or tissue or dissociated 
source cells or  cells preattached to substrate or intact 
tissue resections. The process simultaneously minimizes 
the fluid shear stress, provides 3-dimensional freedom 
for spatial orientation, and extends localization of cells, 
support of respirator; gas exchange, suppiy of nutri- 
ents, and removal of metabolic waste products. This is 
accomplished either by perfusion of media through an 
external media perfusion loop, direct injection to the 
60 culture media, or exchange of these molecules across a 
diffusion membrane. 
This cell and tissue culture process provides a stabi- 
lized environment into which cells or  tissues may be 
introduced, suspended, assembled, grown, and main- 
65 tained with retention of delicate 3-dimensional struc- 
tural integrity. The fluid culture media is initially stabi- 
lized into near solid body horizontal rotation within the 
confines of a similarly rotating vessel wall. The slowest 
5 
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RPM is chosen which will be sufficient to produce 
acceptable particle orbits (with respect to the 3 criteria 
stated in the previous paragraph) upon addition of the 
initial priming load of cells, tissue, and substrates. In 
most cases the initial particles with which the culture is 
primed sediment at a slow rate under 0.1 centimeter per 
second. It is therefore possible to select from a broad 
range of rotational rates (typically 5 to 120 RPM) or 
vessel diameters (typically 0.5 to 36 inches). The slow- 
est rotational rate is advantageous because it minimizes 
equipment wear and other logistics associated with 
handling of the culture. A vessel diameter is chosen 
which has the appropriate volume for the intended 
quantity of cultured material and which will allow a 
sufficient seeding density of cells, tissues, and substrates 
for the availability of these components. 
The following is an exemplary protocol for forming 
and maintaining a multicellular organoid tissue in a slow 
turning lateral vessel (STLV): 
1. An STLV is prepared by tissue culture washing 
and autoclave sterilization. 
2. The sterile, cooled vessel is placed in a Laminar 
Flow Hood and is stood upright. 
3. Average 175 micron microcarrier beads (Cytodex 
3 manufactured by Pharmacia) are hydrated and 
sterilized before hand and diluted into a 20 mg/ml 
solution of beads in growth media. An appropriate 
volume of this 20 mg/ml solution is added to the 
vessel to yield a final bead concentration of 5 
mg/ml in the total volume of the vessel. 
4. The vessel is filled to all but 10% of the total vol- 
ume with growth media. The growth media is 
dependent on the type of cells being cultured in the 
vessel. 
5. The valves are closed and the vessel is placed in a 
37" C. humidified C02 incubator with 95% air 5% 
COz to equilibrate for 1-2 hours. The incubator 
surrounds the STLV and prevents evaporation of 
the media from the STLV system. 
6. Cell preparation required both mixed normal 
human colon fibroblasts and human colon tumor 
cells to be trypsinized from standard culture flasks. 
The two cell types are mixed together in the cor- 
rect ratio (9:l) and placed on ice during the wash 
procedure. After trypsinization the correct cell 
mixture is washed 2 times with phosphate buffered 
saline and suspended in the correct growth media. 
This final cell mixture is held on ice until inocula- 
tion. 
7. After equilibration and cell preparation the vessel 
is inoculated with a cell number which will yield 10 
cellshead of the mixed cell ratio. The total number 
of cells consists of the two cell types (normal 
human colon fibroblasts and human colon tumor 
cells). The cell types are mixed in a ratio that pro- 
motes cooperative effects seen in the later stages of 
the coculture process. Each mg of microcarriers 
contains 4OOO beads. 
8. After inoculation the vessel is filled to volume with 
the growth media of choice and placed in the incu- 
bator. 
9. Initial rotation rates of the vessel are set at 10-15 
rpm. These rotation rates suspend the single cells 
and beads to initiate growth. 
10. After 24 hours, the progress of the culture is in- 
spected and a determination is made on the neces- 
sity for rotational speed. 
6 
11. At 48 hours the first media change usually is made 
predicated on the metabolism and the cells being 
cultured. The growth of the culture is monitored 
by cell counts, glucose, D02,  DCO2 and pH analy- 
12. As the culture develops from 72 hours on, daily 
adjustments are made in the rotational rate of the 
vessel dependent on the size of the cell aggregates. 
13. Cell and bead aggregates form complex cell 
masses which are oriented in a three dimensional 
spatial configuration. 
14. Growth limitation occurs as the experiment pro- 
gresses and increased rotational speed no longer 
sufficiently suspends the particles. In addition, in- 
creased rotational speeds above 35 rpm induce 
centrifugal forces which smash the particles against 
the o.uter wall of the vessel destroying critical 
three-dimensional spatial orientation. 
15. The experiment is terminated when the factors in 
Item 13 are reached and/or when cellular metabo- 
lism in the STLV becomes too demanding to keep 
up with on a daily basis. 
The foregoing protocol of the STLV is only one 
bioreactor device as a specific example which may be 
25 used to carry out the process of, the present invention. 
As specifically set forth hereinabove the process of 
co-culturing may be carried out in the rotating wall 
perfused vessel (RWPV) which is described in the par- 
ent application. 
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EXAMPLE I 
A three dimensional multicellular organoid mamma- 
lian cell culture was initiated in the following manner. 
The culture device, a slow turning lateral vessel 
35 (STLV), was prepared by washing with a tissue culture 
detergent, (micr0.x) and followed by extensive rinses 
and soaking in Milli Q ultra high purity water. The 
device was sterilized by autoclaving and upon cooling 
was rinsed for residuals with culture growth media. The 
40 vessel was placed in a laminar flow hood and stood 
upright. Cytodex 3 microcarrier beads (Pharmacia) 
were hydrated and sterilized before hand and suspended 
in a 20 mg./ml. solution of growth media; each mg. 
containing 4OOO micro carriers. The vessel was filled 
45 with the growth media which consisted of minimal 
essential medium alpha (MEM), supplemented with 
insulin, transferrin, selenium, (5 ug., 10 ug., 5 ug.), epi- 
dermal growth factor, sodium pyruvate, 10% fetal calf 
serum, hepes buffer 2 gramsfliter, and penicillin and 
62.5 ml. of a 20 mg./ml. solution of microcarriers 
were added to the vessel to yield a final concentration 
of 5 mg./ml. of microcarrier in the vessel. The vessel 
was then filled within 10% of the final volume with 
55 growth media. The vessel was sealed and placed in a 
laminar flow COz incubator with 95% air, 5% COz, 
95% humidity at 37" C. to equilibrate for one hour. At 
the end of one hour, the vessel was removed from the 
incubator and inoculated with 5 X 107 cells consisting of 
60 mixed normal human colonic fibroblasts (4 donors) and 
HT-29KM, a partially differentiated human colon ade- 
nocarcinoma. The cells were mixed in a (9:l) ratio. 
After inoculation, the vessel was closed, purged of re- 
maining air bubbles and replaced in the incubator. The 
65 vessel was equipped with a 20 ml. syringe which func- 
tioned as a compliant volume. Daily monitoring of the 
growth in the vessel was accomplished by analysis of 
DC02,  D02,  glucose, mOsm and PH. At 48 hours the 
50 streptomycin (100 units, 100 mg./ml.). 
7 
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growth media was replaced for the first time and each culture detergent, (Micro-x) and followed by extensive 
24-hours thereafter a media change was required. These rinses and soaking in Milli Q water. The device was 
changes were required to remove toxic metabolic by- assembled and then sterilized by Ethylene Oxide gas. 
products and replenish nutrient levels in the vessel. After sterilization, the vessel was placed in a laminar 
Media changes were also necessary to harvest rare 5 flow bench and flushed with mildly acidic ultra pure 
growth products produced from,the interaction of the Milli Q water. At the end of a 16 hour perfusion cycle, 
multicellular organoid culture. On day 2 the rotation the vessel was drained, filled with growth media and 
rate was increased from 12 to 15 RPM. At 168 hours the allowed to stand overnight at room temperature. The 
media composition was altered to include an additional growth media consisted of minimal essential medium 
100 mg./dl. glucose as a result of increased consump- 10 alpha (MEM), supplemented with insulin, transferrin, 
tion. At 216 hours the glucose concentration was in- selenium, (5 ug., 10 ug., 5 ug.), epidermal growth factor, 
creased to 300 mg./dl. again due to the high rate of sodium pyruvate, 10% fetal calf serum, hepes buffer 2 
consumption. From 138 hours on the culture exhibited gramsfliter, and penicillin and streptomycin (100 units, 
cell to celI organization. At 216 hours the presence of 100 mg./ml.). The following day the vessel was drained 
well developed multicellular organoid structures were 15 and refilled with fresh growth media and 2.5 grams of 
visible. These structures took on the appearance of Cytodex 3 micro carriers. The vessel was placed in a 
circular structures or pseudocrypts. The- culture was 
terminated at 288 hours to begin analysis of the well 
developed cellular material contained in the vessel. The 
growth media from the vessel was harvested and placed 
at - 80" C .  for future analysis. The cellular material was 
removed and analyzed for structural components. 
The three dimensional multicellular organoid tissue 
was imbedded in paraffin blocks and cut in 10 and 20 
micron sections. These sections were then stained with 
mucicamine or hematoxylin and eosin. This histologi- 
cal staining yielded the presence of microscopic cellular 
organization which was determined to be pseudo-gland 
formation. In addition, scanning electronmicroscopy 
showed definite pseudo-crypt formation and the pres- 
ence of organized tubular structures. 
EXAMPLE 2 
A three dimensional multicellular organoid mamma- 
lian cell culture was initiated in the same manner as 
described in Example 1. 
After removal from the incubator for equilibration, 
the vessel was inoculated with 5.0X IO7 cells consisting 
of mixed normal human colon fibroblasts (4 donors) and 
HT-29 a pluripotent human adenocarcinoma of the 
colon. The cell types were mixed in a ratio of (9:l). 
After inoculation, the vessel was treated as described in 
Example 1. Daily monitoring was accomplished as 
stated in Example 1. At 48-hours into the culture the 
growth media was replaced as in Example 1. The rota- 
tion rate was increased on Day 3 from 10 to 14 RPM. At 
167 hours into the culture the concentration of glucose 
in the media was raised from 100 to 200 mg./dl. This 
was a result of the increased metabolism of the culture. 
At 264 hours into the culture the growth of the tissues 
required a second increase in glucose concentration to 
300 mg./dl. The run was terminated at 408 hours. As in 
Example 1 the vessel materials were harvested and 
processed in a similar fashion. 
Upon processing of the tissues from this cell experi- 
ment, the multicellular organoid tissues expressed orga- 
nized polypoid structures. 
These polypoid structures were visible both micro- 
scopically and macroscopically with the final tissue size 
approaching 1 cm. Scanning electronmicroscopy re- 
vealed an enhanced view of complex polypoid develop- 
ment. 
EXAMPLE 3 
A three dimensional multicellular organoid mamma- 
lian cell culture was initiated in the following manner. 
The culture device, a rotating wall perfused vessel (500 
ml. Volume), was prepared by washing with a tissue 
C02 incubator with 95% air, 5% C02 and 95% humid- 
ity to equilibrate for two hours. After equilibration, the 
vessel was removed from the incubator and inoculated 
20 with 1.OX 108 cells consisting of mixed normal human 
colonic fibroblasts (4 donors) and HT-29, a pluripotent 
human adenocarcinoma of the colon. The cell types 
were mixed in a (9:l) ratio. 
After inoculation the rotating wall perfused vessel 
25 was placed in the laminar flow incubator. The vessel 
was equipped with a 20 ml. syringe which functioned as 
a compliant volume. The initial wall, vane, and spin 
filter rotations were set at 18-20 RPM. The perfusion 
pump was left off for the first 9 hours of the run. At 9 
30 hours into the experiment the pump rate was set at 2.5 
ml./min. Daily monitoring of the growth in the vessel 
was accomplished by analysis of DC02, DO2, glucose, 
mOsm and pH. At 48 hours 600 ml. of fresh growth 
media was perfused into the vessel. This procedure 
35 removed any dead or non-attached cells. At 96-hours 
the vessel was perfused with 600 ml. of fresh growth 
media to remove toxic metabolic by-products and re- 
plenish nutrient levels. At 120-hours the in-line filter 
became clogged with debris from the rotating seals and 
40 the emergency by-pass valve was opened. In addition, 
600 ml. of fresh media was also perfused at this time 
point. At 167 hours into the experiment 600 ml. of 200 
mg./dl. glucose growth media was perfused into the 
vessel. 
At 192 hours into the experiment the perfusion pump 
rate was increased from 2.5 to 4.0 ml./min. and 600 ml. 
of fresh media was perfused into the vessel. The pump 
rate was increased to 6 ml./min. at 216 hours and 600 
ml. of fresh media was perfused into the system. At 264 
50 hours the pump rate was increased to 9 ml./min. and 
fresh media (600 ml.) was added to the system. At this 
point the glucose concentration had to be increased to 
300 mg./dl. At 288 hours the pump rate was increased 
to 10 ml./min. and 600 ml. of 300 mg./dl. glucose was 
55 perfused. The pump rate was increased to 11.5 ml./min. 
at 314 hours and 20 ml. of 50 mg./ml. glucose was 
added to the system. At 360 hours the pump rate was 
increased to 13 ml./min. and 600 ml. of 300 mg./dl. 
glucose growth media was perfused. 600 ml. of 300 
60 mg./dl. glucose media was perfused at 384 hours. The 
experiment was terminated at 408 hours. From 167 
hours into the experiment through to the end the cul- 
ture exhibited multicellular, structural development. 
Polypoid formation was evident at first by light micros- 
65 copy and later macroscopically. The growth media was 
harvested from the vessel and placed at -80" C .  for 
later analysis. The multicellular tissue material was 
removed from the vessel and divided into samples for 
45 
5,153,132 
9 10 
analysis. Analysis of the three dimensional organoid 
tissue which had been imbedded in paraffin and sec- 
tioned, revealed the presence of complex polypoid 
structures and specific areas of cellular differentiation. 
These determinations were made by means of mucicar- 5 
mine and hematoxylin and eosin stains. 
determining the trajectory of the tissues, in response 
to said determining step: increasing the speed of 
rotation of the culture chamber if the tissues fall 
excessively inward and downward on the down- 
ward side of the rotational cycle and excessively 
outward and insufficiently upward on the upgoing 
side of the rotational cycle to prevent wall impact; 
or decreasing the speed of rotation of the culture 
chamber in response to excessive accumulation of 
the tissues near the outer wall of the culture cham- 
ber so as not to restrict three dimensional assembly, 
and as the size of the tissues increase beyond the 
capability to fully satisfy the above three properties 
by further increase of the speed of rotation, select- 
ing a rotational rate to visually obtain minimal 
collision frequency and intensity. 
2. The method specified in claim 1 in which one of the 
cell types are stromal cells and the other cell types are 
epithelial cells. 
3. The method specified in claim in which one of the 
cell types are fibroblasts and the other cell types are 
pluripotent human adenocarcinoma. 
4. The method specified in claim in which one ofthe 
cell types are normal human colon fibroblasts and the 
5. The method specified in claim 4 in which the fibro- 
blasts and tumor cells are at a g:1 ratio, 
6. The method of claim 1 wherein the vessel is located 
in microgravity, 
7. The method of claim 1 wherein the vessel is located 
in unit gravity. 
8. The method of claim 7 wherein the vessel is rotated 
within the range of 5 and 25 RPM, and the RPM is 
increased as the density of the assembly increases. 
9. The method of claim 1 wherein the method of 
sustaining said media is by perfusion. 
10. The method of claim 1 wherein the cell attach- 
ment substrates are microcarrier beads. 
We claim: 
1. A method for culturing at least two distinct origi- 
nating types of mammalian cells to produce in vitro 
multi-cellular, three-dimensional, differentiated, orga- 10 
nized, living tissues, said method including the steps of: 
providing a bioreactor having a culture chamber 
rotatable about an approximately horizontal longi- 
tudinal axis, means to controllably rotate said cul- 
ture chamber, means to oxygenate said culture 
chamber and means to remove metabolic waste 
products therefrom; 
filling said culture chamber completely with a fluid 
nutrient media, cell attachment substrates, and indi- 2o 
vidually dispersed 
distinct types to establish a culturing environment; 
rotating said culture chamber about its longitudinal 
axis, oxygenating the culturing environment within 
said chamber and removing 
waste products therefrom; 
controlling the rotation of said culture chamber such 
that the culturing environment except during Iran- 
sient periods has the following simultaneous prop- 
erties: 
a. collocation of cells and attachment substrates 
with similar or differing sedimentation proper- 
ties in a similar spatial region, 
b. freedom for three dimensional spatial orientation 
of tissues formed by the culturing of the cells, 35 
and 
c. low shear and essentially no relative motion of 
said culturing environment with respect to the 
walls of the culture chamber; and 
15 
Of at least 
25 other cell types are human colon tumor cells. 
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